191 related articles for article (PubMed ID: 26796639)
1. Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamster.
Khokhar JY; Green AI
Neuropharmacology; 2016 Jun; 105():25-34. PubMed ID: 26796639
[TBL] [Abstract][Full Text] [Related]
2. Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan.
Khokhar JY; Chau DT; Dawson R; Green AI
Drug Alcohol Depend; 2015 Jul; 152():277-81. PubMed ID: 25979645
[TBL] [Abstract][Full Text] [Related]
3. Desipramine enhances the ability of paliperidone to decrease alcohol drinking.
Chau DT; Khokhar JY; Gulick D; Dawson R; Green AI
J Psychiatr Res; 2015 Oct; 69():9-18. PubMed ID: 26343589
[TBL] [Abstract][Full Text] [Related]
4. Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster.
Gulick D; Chau DT; Khokhar JY; Dawson R; Green AI
Psychiatry Res; 2014 Aug; 218(3):329-34. PubMed ID: 24836200
[TBL] [Abstract][Full Text] [Related]
5. Clozapine reduces alcohol drinking in Syrian golden hamsters.
Green AI; Chau DT; Keung WM; Dawson R; Mesholam RI; Schildkraut JJ
Psychiatry Res; 2004 Aug; 128(1):9-20. PubMed ID: 15450910
[TBL] [Abstract][Full Text] [Related]
6. Raclopride lessens the ability of clozapine to suppress alcohol drinking in Syrian golden hamsters.
Chau DT; Ahmed J; Wang TT; Xie H; Dawson R; Green AI
Neuropharmacology; 2011 Sep; 61(4):646-52. PubMed ID: 21619888
[TBL] [Abstract][Full Text] [Related]
7. Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters.
Chau DT; Gulick D; Xie H; Dawson R; Green AI
Neuropharmacology; 2010 Feb; 58(2):351-6. PubMed ID: 19895824
[TBL] [Abstract][Full Text] [Related]
8. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Kalkman HO; Loetscher E
Eur J Pharmacol; 2003 Feb; 462(1-3):33-40. PubMed ID: 12591093
[TBL] [Abstract][Full Text] [Related]
9. The comparative effects of clozapine versus haloperidol on initiation and maintenance of alcohol drinking in male alcohol-preferring P rat.
Chau DT; Khokhar JY; Dawson R; Ahmed J; Xie H; Green AI
Alcohol; 2013 Dec; 47(8):611-8. PubMed ID: 24280363
[TBL] [Abstract][Full Text] [Related]
10. Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.
Kalkman HO; Subramanian N; Hoyer D
Neuropsychopharmacology; 2001 Dec; 25(6):904-14. PubMed ID: 11750183
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
13. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
[TBL] [Abstract][Full Text] [Related]
14. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
[TBL] [Abstract][Full Text] [Related]
15. An update on the efficacy and safety of iloperidone as a schizophrenia therapy.
Nair A; Salem A; Asamoah AL; Gosal R; Grossberg GT
Expert Opin Pharmacother; 2020 Oct; 21(15):1793-1798. PubMed ID: 32735148
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm.
Gemperle AY; McAllister KH; Olpe HR
Psychopharmacology (Berl); 2003 Sep; 169(3-4):354-64. PubMed ID: 12827343
[TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study.
Gemperle AY; Enz A; Pozza MF; Lüthi A; Olpe HR
Neuroscience; 2003; 117(3):681-95. PubMed ID: 12617972
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
19. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
Szewczak MR; Corbett R; Rush DK; Wilmot CA; Conway PG; Strupczewski JT; Cornfeldt M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1404-13. PubMed ID: 7562515
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic.
Sainati SM; Hubbard JW; Chi E; Grasing K; Brecher MB
J Clin Pharmacol; 1995 Jul; 35(7):713-20. PubMed ID: 7560252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
